UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

OncoCalendar

« All Events

  • This event has passed.

SOHO 2025

Sep 3 • 12:00 AM - Sep 6 • 12:00 AM
SOHO 2025

The 13th annual meeting of the Society of Hematologic Oncology (SOHO 2025) will take place from September 3-6, 2025, at the GRB Convention Center in Houston, Texas.

SOHO 2025 will be a hybrid event, providing options for in-person, virtual, and on-demand participation. As the only global society dedicated to hematologic malignancies, the Society of Hematologic Oncology (SOHO) brings together leading experts to deliver a dynamic and informative program. The 2025 meeting will focus on the latest advances and practical clinical applications in hematologic oncology, with a multidisciplinary group of internationally recognized speakers addressing a wide range of diseases.

The meeting is expected to attract over 3,800 healthcare professionals, including physicians, nurses, and specialists, for a 3.5-day educational experience. Attendees will have the opportunity to engage in a variety of educational formats, such as General Sessions, Meet-the-Professor Sessions, Plenary Lectures, Expert Sessions, Oral Abstract Presentations, and interactive discussions.

The theme for SOHO 2025 is “TBD,” and the program will cover exciting advancements in the pathophysiology and treatment of leukemias, lymphomas, myeloma, myelodysplastic and myeloproliferative neoplasms, related malignancies, and cellular therapies.

For Registration, Visit Here.

Details

Organizer

Venue